Digestive Diseases and Sciences

, Volume 54, Issue 6, pp 1284–1291

Atypical Antipsychotic Quetiapine in the Management of Severe Refractory Functional Gastrointestinal Disorders

  • Madhusudan Grover
  • Spencer D. Dorn
  • Stephan R. Weinland
  • Christine B. Dalton
  • Bradley N. Gaynes
  • Douglas A. Drossman
Original Article

DOI: 10.1007/s10620-009-0723-6

Cite this article as:
Grover, M., Dorn, S.D., Weinland, S.R. et al. Dig Dis Sci (2009) 54: 1284. doi:10.1007/s10620-009-0723-6

Abstract

Management of severe refractory functional gastrointestinal disorders (FGIDs) is difficult. Quetiapine, an atypical antipsychotic, may benefit patients by mitigating associated anxiety and sleep disturbances, augmenting the effect of antidepressants, and providing an independent analgesic effect. Outpatient records from a university-based FGID clinic were reviewed, and 21 patients with refractory symptoms who received quetiapine were identified and interviewed. Outcomes included global relief of symptoms, treatment efficacy questionnaire, and change in gastrointestinal (GI) and psychological symptoms. Eleven of 21 patients continued therapy at the time of interview. Six of 11 demonstrated global relief of symptoms, and 9 were satisfied with treatment. The remaining 10 of 21 discontinued therapy because of somnolence and lack of GI benefits. Quetiapine in low doses appeared beneficial in more than half of the adults with severe FGIDs who stayed on treatment. This response in otherwise refractory patients suggests quetiapine might augment the effectiveness of antidepressants in severe FGIDs.

Keywords

Irritable bowel syndrome Functional gastrointestinal disorders Treatment Psychotropic agents Antidepressants Quetiapine Atypical antipsychotics 

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Madhusudan Grover
    • 1
    • 2
  • Spencer D. Dorn
    • 1
  • Stephan R. Weinland
    • 1
  • Christine B. Dalton
    • 1
  • Bradley N. Gaynes
    • 1
  • Douglas A. Drossman
    • 1
  1. 1.Center for Functional GI and Motility DisordersUniversity of North Carolina at Chapel HillChapel HillUSA
  2. 2.Department of Internal MedicineMichigan State UniversityEast LansingUSA

Personalised recommendations